NYSE:EW - Edwards Lifesciences Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $177.03 -0.75 (-0.42 %) (As of 02/20/2019 06:00 AM ET)Previous Close$177.78Today's Range$176.44 - $178.6852-Week Range$123.00 - $178.68Volume725,226 shsAverage Volume1.09 million shsMarket Capitalization$36.78 billionP/E Ratio37.83Dividend YieldN/ABeta0.92 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Edwards Lifesciences (NYSE:EW) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.20 Wall Street analysts have issued ratings and price targets for Edwards Lifesciences in the last 12 months. Their average twelve-month price target is $169.10, suggesting that the stock has a possible downside of 4.48%. The high price target for EW is $200.00 and the low price target for EW is $119.00. There are currently 2 sell ratings, 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.502.522.532.70Ratings Breakdown: 2 Sell Rating(s)6 Hold Rating(s)12 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)6 Hold Rating(s)13 Buy Rating(s)0 Strong Buy Rating(s)2 Sell Rating(s)5 Hold Rating(s)12 Buy Rating(s)0 Strong Buy Rating(s)1 Sell Rating(s)4 Hold Rating(s)15 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $169.10$166.0476$155.2222$151.7895Price Target Upside: 4.48% downside4.36% upside8.67% upside9.94% upsideEdwards Lifesciences (NYSE:EW) Consensus Price Target History Edwards Lifesciences (NYSE:EW) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/4/2019CowenReiterated RatingBuyMedium2/3/2019Stifel NicolausReiterated RatingBuy$190.00Medium1/18/2019Bank of AmericaUpgradeNeutral ➝ Buy$180.00 ➝ $190.00High1/16/2019Canaccord GenuityBoost Price TargetBuy ➝ Positive$177.00 ➝ $186.00High1/2/2019Deutsche BankInitiated CoverageHold ➝ Hold$164.00High1/2/2019CitigroupBoost Price TargetSell ➝ Sell$118.00 ➝ $119.00Low12/17/2018Credit Suisse GroupInitiated CoverageOutperform$188.00Low12/7/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$157.00 ➝ $180.00Medium12/6/2018Raymond JamesBoost Price TargetOutperform ➝ Outperform$160.00 ➝ $175.00High12/6/2018Royal Bank of CanadaBoost Price TargetOutperform$175.00High12/6/2018Jefferies Financial GroupBoost Price TargetPositive ➝ Buy$168.00 ➝ $180.00High11/27/2018UBS GroupInitiated CoverageNeutral ➝ Neutral$165.00 ➝ $165.00High10/24/2018BarclaysSet Price TargetSell$143.00High10/11/2018Northland SecuritiesReiterated RatingHold$120.00Medium10/2/2018GuggenheimDowngradeBuy ➝ NeutralHigh9/28/2018SunTrust BanksBoost Price TargetBuy$200.00Medium7/27/2018Wells Fargo & CoBoost Price TargetOutperform ➝ Outperform$152.00 ➝ $170.00Medium7/27/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$133.00 ➝ $150.00High7/10/2018BMO Capital MarketsBoost Price TargetOutperform$162.00Low6/27/2018Sanford C. BernsteinInitiated CoverageMarket Perform$165.00High2/2/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$135.00 ➝ $140.00High1/3/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$140.00High8/28/2017William BlairReiterated RatingOutperform ➝ OutperformLow5/16/2017Goldman Sachs GroupInitiated CoverageConviction-Buy$138.00Low(Data available from 2/20/2017 forward) This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?